Bionik Laboratories Profit Margin

Bionik Laboratories (BNKL) currently reports a profit margin of -280.69% as of March 2023. That compares with -1249.31% in the prior-year period — up 77.5% year over year. That is below the sector sector average of 13.16%. Use the charts on this page to explore Bionik Laboratories's profit margin history and peer comparisons.

Bionik Laboratories's profit margin increased from -1249.31% to -280.69% — a 77.5% year-over-year increase (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bionik Laboratories's profit margin of -280.69% is lower than the its sector sector average of 13.16%. That is roughly 2232.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Bionik Laboratories's current -280.69% should be judged against industry norms (sector average: 13.16%) and against BNKL's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -280.69%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.16%. From there, open related valuation or income-statement pages for Bionik Laboratories, and consider following BNKL for alerts when major investors trade the stock.